The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Protagonist Therapeutics (PTGX – Research Report) and Roche ...
MyChesCo on MSN22h
FDA Approves Lifesaving Stroke Drug, Xarelto Generics, and Issues Urgent Testosterone WarningsThe U.S. Food and Drug Administration (FDA) has released several important updates addressing new medication approvals and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback